Tampa's Oragenics Closes $2 Million Equity Round

TAMPA - Biopharmaceutical company Oragenics Inc. has closed on $2 million in equity and debt financing round, according to a regulatory filing with the SEC. The company is funded by Koski Family Limited Partnership.

Oragenics engages in the discovery, development, and commercialization of various products and technologies associated with oral health, antibiotics, and other general health benefits in the United States. Founded in 1996, it is headquartered in Tampa and has research and development facilities in Alachua.

Website: www.oragenics.com